Mon, Feb 22, 2021
Healthcare Services Sector Update – January 2021
The S&P Healthcare Services Index increased by 6.5% over the last month, compared to the S&P 500 Index, which increased 1.1% over the same period.
Over the past month:
- The sectors that experienced the most growth were Telemedicine (up 33.3%), Consumer Directed Health/Wellness (up 18.1%) and Providers – Other (up 14.8%).
- The sectors that experienced the largest decline was Behavioral Health (down 7.9%), Care Management/TPA (down 4.5%) and Commercial Managed Care (down 3.9%).
- The current average Last Twelve Months (LTM) revenue and LTM EBITDA multiples for the healthcare services industry overall are 1.97x and 10.7x, respectively.
The sectors with the highest valuation multiples include:
- Home Health/Hospice (3.15x LTM revenue, 27.9x LTM EBITDA)
- HCIT (4.26x LTM revenue, 27.5x LTM EBITDA)
- Consumer Directed Health/Wellness (3.81x LTM revenue, 21.3x LTM EBITDA)
- Contract Research Organizations (3.63x LTM revenue, 21.3x LTM EBITDA)
Corporate Finance and Restructuring
M&A advisory, restructuring and insolvency, debt advisory, strategic alternatives, transaction diligence and independent financial opinions.
Healthcare Investment Banking
Healthcare expertise for middle-market M&A transactions.
Distressed M&A and Special Situations
Kroll professionals have advised hundreds of companies, investors and other stakeholders at all stages of distressed transactions and special situations.
Transaction Advisory Services
Kroll’s Transaction Advisory Services platform offers corporate and financial investors with deep accounting and technical expertise, commercial knowledge, industry insight and seamless analytical services throughout the deal continuum.
Fairness and Solvency Opinions
Duff & Phelps Opinions is a global leader in Fairness Opinions and Special Committee Advisory, ranking #1 for total number of U.S. and global fairness opinions over the past 10 years, according to Refinitiv cumulative data from 2013-2022.
Financial Sponsors Group
Dedicated coverage and access to M&A deal-flow for financial sponsors.